Literature DB >> 14595840

Highly efficient transgene-independent recombination directed by a maternally derived SOX2CRE transgene.

Stéphane D Vincent1, Elizabeth J Robertson.   

Abstract

The Cre/loxP site-specific recombination system is a powerful tool that allows gene inactivation in a tissue- and time-specific manner. Several reports have shown that the Sox2Cre transgenic strain provides a very efficient means to delete gene function from the early epiblast (Hayashi et al.: Gene Expr Patterns 2:93-97, 2002; Vincent et al.: Genes Dev 17:1646-1662, 2003). Routinely, male studs carrying one null allele of the gene of interest and the Cre transgene are crossed to females homozygous for the conditional allele. Normally, excision is observed only in the progeny inheriting both the Cre transgene and the conditional allele. Here we report that when the Sox2Cre transgene is inherited maternally, excision occurs in all offspring irrespective of whether they carry the Cre transgene. Thus, Sox2Cre females provide a generally useful tool for rapid and efficient removal of loxP flanked sequences in vivo. Copyright 2003 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2003        PMID: 14595840     DOI: 10.1002/gene.10226

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  18 in total

1.  Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors:  Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

Review 2.  Finding degrees of separation: experimental approaches for astroglial and oligodendroglial cell isolation and genetic targeting.

Authors:  Li-Jin Chew; Cynthia A DeBoy; Vladimir V Senatorov
Journal:  J Neurosci Methods       Date:  2014-08-26       Impact factor: 2.390

3.  Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation.

Authors:  Jiu-Zhen Jin; Jixiang Ding
Journal:  Dev Biol       Date:  2013-06-07       Impact factor: 3.582

4.  Mice develop normally in the absence of Smad4 nucleocytoplasmic shuttling.

Authors:  Christine A Biondi; Debipriya Das; Michael Howell; Ayesha Islam; Elizabeth K Bikoff; Caroline S Hill; Elizabeth J Robertson
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

5.  Development of a unique system for spatiotemporal and lineage-specific gene expression in mice.

Authors:  Hsiao-Man Ivy Yu; Bo Liu; Shang-Yi Chiu; Frank Costantini; Wei Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-07       Impact factor: 11.205

6.  A dual-fluorescence reporter in the Eomes locus for live imaging and medium-term lineage tracing.

Authors:  Simone Probst; Ray A Daza; Natalie Bader; Jonas F Hummel; Matthias Weiß; Yakup Tanriver; Robert F Hevner; Sebastian J Arnold
Journal:  Genesis       Date:  2017-07-14       Impact factor: 2.487

7.  Male germline recombination of a conditional allele by the widely used Dermo1-cre (Twist2-cre) transgene.

Authors:  Yun He; Xiumei Sun; Li Wang; Yuji Mishina; Jun-Lin Guan; Fei Liu
Journal:  Genesis       Date:  2017-08-14       Impact factor: 2.487

8.  Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse.

Authors:  Sebastian J Arnold; Ulf K Hofmann; Elizabeth K Bikoff; Elizabeth J Robertson
Journal:  Development       Date:  2008-01-02       Impact factor: 6.868

9.  c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo.

Authors:  Chen He; Huiqing Hu; Rickmer Braren; Shun-Yin Fong; Andreas Trumpp; Timothy R Carlson; Rong A Wang
Journal:  Development       Date:  2008-06-11       Impact factor: 6.868

10.  Generation of mice with a conditional Foxp2 null allele.

Authors:  Catherine A French; Matthias Groszer; Christopher Preece; Anne-Marie Coupe; Klaus Rajewsky; Simon E Fisher
Journal:  Genesis       Date:  2007-07       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.